CONFIPEN
Live / Applied — First extension granted (statement of use) (as of 29 Oct 2025)
What this means for you
Not registered yet, but its 15 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98649565
- Mark type
- Stylized text
- Filed
- 15 Jul 2024
- Published for opposition
- 01 Apr 2025
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: Injectors for medical purposes pre-filled with pharmaceutical preparations for treating cancer, immune, cardiovascular, metabolic and inflammatory diseases and conditions
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 29 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2025 — SOU EXTENSION 1 GRANTED
- 28 Oct 2025 — SOU EXTENSION 1 FILED
- 28 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Apr 2025 — PUBLISHED FOR OPPOSITION
- 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 10 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
- 10 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
- 05 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE